FDG PET in response evaluation of bulky masses in paediatric Hodgkin's lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial.
Egesta LopciMaurizio MascarinArnoldo PiccardoAngelo CastelloCaterina EliaLuca GuerraEugenio BorsattiAlessandra SalaAlessandra TodescoPietro ZucchettaPiero FarruggiaAngelina CistaroSalvatore BuffardiPatrizia BertoliniMaurizio BianchiMaria Luisa MoletiFeisal BunkheilaPaolo IndolfiFranca FagioliAlberto GaraventaRoberta Burnellinull nullPublished in: European journal of nuclear medicine and molecular imaging (2018)
After four cycles of chemotherapy, FDG PET response assessment in paediatric HL patients with a bulky mass is a good predictor of TTP and disease outcome. Moreover, in patients with a PR on CT, PET was able to differentiate those with a longer TTP. In paediatric HL patients with a bulky mass and in patients with a PR on CT, response on FDG PET was an independent predictive factor.
Keyphrases
- positron emission tomography
- pet ct
- pet imaging
- computed tomography
- intensive care unit
- emergency department
- contrast enhanced
- end stage renal disease
- dual energy
- newly diagnosed
- image quality
- magnetic resonance imaging
- chronic kidney disease
- prognostic factors
- study protocol
- randomized controlled trial
- diffuse large b cell lymphoma
- peritoneal dialysis
- ultrasound guided
- phase iii